FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162594920> ?p ?o ?g. }

• W2162594920 endingPage "498" @default.
• W2162594920 startingPage "489" @default.
• W2162594920 abstract "Green tea and its major active constituent, (-)-epigallocatechin-3-gallate (EGCG), are in clinical trials for the prevention and treatment of several diseases such as cancer. DNA topoisomerase (topo) poisons are commonly prescribed anticancer drugs that kill cancer cells by inducing topo-DNA complexes. Using purified topoisomerases, previous in vitro studies have shown that EGCG induces the formation of topo-DNA complexes. Because the activity of a drug on purified topoisomerases does not always represent the activity in a cell, we have used an immunofluorescence technique that allows the visualisation of topo I- and topo II-DNA complexes produced in individual cells to evaluate the activity of EGCG on both enzymes. High levels of topo I- and topo II-DNA complexes were observed in K562 leukaemia cells exposed to EGCG. Similar levels of topo I- and topo II-DNA complexes were visualised in cells treated with gallic acid (GA) (the acid part of the EGCG ester). Pyrogallol (PG) also induced topo-DNA complexes with both enzymes, therefore suggesting that the activity of EGCG and GA is mediated by their PG moieties. Catalase prevented both the cytotoxicity and the formation of topo I- and topo II-DNA complexes induced by EGCG, GA, PG and myricetin (a PG-containing flavonoid recently shown to induce topo I- and topo II-DNA complexes in cells), indicating that hydrogen peroxide mediates these activities. Hydrogen peroxide induced topo I- and topo II (α and β)-DNA complexes in a time- and dose-dependent manner. The formation of topo I- and topo II-DNA complexes in cells exposed to hydrogen peroxide correlated well with the induction of apoptosis, suggesting that the topo-DNA complexes induced at long exposure times by the compounds tested in our study may be apoptotic topo-DNA complexes. Finally, we report results suggesting that PG-containing drugs may selectively kill tumour cells by generating hydrogen peroxide." @default.
• W2162594920 created "2016-06-24" @default.
• W2162594920 creator A5006061477 @default.
• W2162594920 creator A5022208465 @default.
• W2162594920 creator A5051071578 @default.
• W2162594920 creator A5088390075 @default.
• W2162594920 date "2011-03-07" @default.
• W2162594920 modified "2023-10-01" @default.
• W2162594920 title "Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide" @default.
• W2162594920 cites W11654018 @default.
• W2162594920 cites W1420156288 @default.
• W2162594920 cites W1587615774 @default.
• W2162594920 cites W1966517854 @default.
• W2162594920 cites W1970530418 @default.
• W2162594920 cites W1975204412 @default.
• W2162594920 cites W1977037331 @default.
• W2162594920 cites W1980021465 @default.
• W2162594920 cites W1987053877 @default.
• W2162594920 cites W1987595432 @default.
• W2162594920 cites W1991893795 @default.
• W2162594920 cites W1992652784 @default.
• W2162594920 cites W1996902469 @default.
• W2162594920 cites W1997337342 @default.
• W2162594920 cites W2000683639 @default.
• W2162594920 cites W2011006339 @default.
• W2162594920 cites W2011624740 @default.
• W2162594920 cites W2015758149 @default.
• W2162594920 cites W2019251970 @default.
• W2162594920 cites W2029785429 @default.
• W2162594920 cites W2031372644 @default.
• W2162594920 cites W2031855999 @default.
• W2162594920 cites W2035476026 @default.
• W2162594920 cites W2036292892 @default.
• W2162594920 cites W2038375271 @default.
• W2162594920 cites W2039706098 @default.
• W2162594920 cites W2040829831 @default.
• W2162594920 cites W2042364179 @default.
• W2162594920 cites W2048517151 @default.
• W2162594920 cites W2051499819 @default.
• W2162594920 cites W2066022538 @default.
• W2162594920 cites W2066174558 @default.
• W2162594920 cites W2066661956 @default.
• W2162594920 cites W2067266295 @default.
• W2162594920 cites W2067578884 @default.
• W2162594920 cites W2069704309 @default.
• W2162594920 cites W2070455847 @default.
• W2162594920 cites W2077785291 @default.
• W2162594920 cites W2082876519 @default.
• W2162594920 cites W2084166182 @default.
• W2162594920 cites W2086876342 @default.
• W2162594920 cites W2095646094 @default.
• W2162594920 cites W2109533700 @default.
• W2162594920 cites W2114351091 @default.
• W2162594920 cites W2115868186 @default.
• W2162594920 cites W2124624490 @default.
• W2162594920 cites W2125892666 @default.
• W2162594920 cites W2131878763 @default.
• W2162594920 cites W2132302033 @default.
• W2162594920 cites W2132600317 @default.
• W2162594920 cites W2132960195 @default.
• W2162594920 cites W2135642745 @default.
• W2162594920 cites W2137298388 @default.
• W2162594920 cites W2142749576 @default.
• W2162594920 cites W2145128878 @default.
• W2162594920 cites W2155060586 @default.
• W2162594920 cites W2157653515 @default.
• W2162594920 cites W2161431747 @default.
• W2162594920 cites W2252366018 @default.
• W2162594920 cites W2297718137 @default.
• W2162594920 cites W2341695868 @default.
• W2162594920 cites W2435423638 @default.
• W2162594920 doi "https://doi.org/10.1093/mutage/ger006" @default.
• W2162594920 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21382914" @default.
• W2162594920 hasPublicationYear "2011" @default.
• W2162594920 type Work @default.
• W2162594920 sameAs 2162594920 @default.
• W2162594920 citedByCount "59" @default.
• W2162594920 countsByYear W21625949202012 @default.
• W2162594920 countsByYear W21625949202013 @default.
• W2162594920 countsByYear W21625949202014 @default.
• W2162594920 countsByYear W21625949202015 @default.
• W2162594920 countsByYear W21625949202016 @default.
• W2162594920 countsByYear W21625949202017 @default.
• W2162594920 countsByYear W21625949202018 @default.
• W2162594920 countsByYear W21625949202019 @default.
• W2162594920 countsByYear W21625949202020 @default.
• W2162594920 countsByYear W21625949202021 @default.
• W2162594920 countsByYear W21625949202022 @default.
• W2162594920 countsByYear W21625949202023 @default.
• W2162594920 crossrefType "journal-article" @default.
• W2162594920 hasAuthorship W2162594920A5006061477 @default.
• W2162594920 hasAuthorship W2162594920A5022208465 @default.
• W2162594920 hasAuthorship W2162594920A5051071578 @default.
• W2162594920 hasAuthorship W2162594920A5088390075 @default.
• W2162594920 hasBestOaLocation W21625949201 @default.
• W2162594920 hasConcept C109316439 @default.
• W2162594920 hasConcept C143425029 @default.
• W2162594920 hasConcept C147897179 @default.

• next